Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Chronic utilization of agents acting on the renin-angiotensin system and intraoperative arterial pressure.

Castanheira L, de Lurdes Castro M, Calheiros J.

Eur Rev Med Pharmacol Sci. 2013 Feb;17(4):451-6.

2.
3.

Manidipine treatment in patients with albuminuria not sufficiently reduced with renin-angiotensin system blockers.

Galceran J, Plana J, Felip A, Pou G, Vila J, Sobrino J.

Expert Rev Cardiovasc Ther. 2010 Jun;8(6):751-7. doi: 10.1586/erc.10.48. Review.

PMID:
20528630
4.
5.

Rationale for the use of a fixed-dose combination in the management of hypertension: efficacy and tolerability of lercanidipine/enalapril.

Borghi C, Cicero AF.

Clin Drug Investig. 2010;30(12):843-54. doi: 10.2165/11584470-000000000-00000. Review. Erratum in: Clin Drug Investig. 2011;31(8):572.

PMID:
20923243
6.

Angiotensin II receptor antagonists. Potential in elderly patients with cardiovascular disease.

Burrell LM, Johnston CI.

Drugs Aging. 1997 Jun;10(6):421-34. Review.

PMID:
9205848
7.

The renin-angiotensin system, the kidney, and hypertension.

Rosenfeld JB, Zabludowski J.

J Cardiovasc Pharmacol. 1989;13 Suppl 3:S22-6. Review.

PMID:
2474096
8.

Treatment of hypertension with renin-angiotensin system inhibitors and renal dysfunction: a systematic review and meta-analysis.

Daien V, Duny Y, Ribstein J, du Cailar G, Mimran A, Villain M, Daures JP, Fesler P.

Am J Hypertens. 2012 Jan;25(1):126-32. doi: 10.1038/ajh.2011.180. Epub 2011 Oct 13. Review.

PMID:
21993366
9.
10.

Management of high-risk hypertensive patients with diabetes: potential role of angiotensin II receptor antagonists.

Weber MA, Weir MR.

J Clin Hypertens (Greenwich). 2001 Jul-Aug;3(4):225-35. Review.

11.

Atherosclerotic renal artery stenosis: update on management strategies.

Meier P.

Curr Opin Cardiol. 2011 Nov;26(6):463-71. doi: 10.1097/HCO.0b013e32834a6fe8. Review.

PMID:
21799405
12.

The role of renin inhibition in treating the hypertensive patient with diabetes: a summary of preclinical and clinical evidence.

Abdellatif AA.

Expert Rev Cardiovasc Ther. 2012 Feb;10(2):251-63. doi: 10.1586/erc.11.186. Review.

PMID:
22292880
13.

The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.

Thomas GN, Chan P, Tomlinson B.

Drugs Aging. 2006;23(2):131-55. Review.

PMID:
16536636
14.
15.

Aliskiren, the first approved renin inhibitor: Clinical application and safety in the treatment of hypertension.

Riccioni G, Vitulano N, D'Orazio N, Bellocci F.

Adv Ther. 2009 Jul;26(7):700-10. doi: 10.1007/s12325-009-0050-5. Epub 2009 Jul 27. Review.

PMID:
19649581
16.

Systematic review on urine albumin testing for early detection of diabetic complications.

Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.

Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.

17.
18.

The role of direct renin inhibition in clinical practice: focus on combination therapy.

Rashid HU, Mende C.

Am J Cardiovasc Drugs. 2011 Oct 1;11(5):303-15. doi: 10.2165/11594140-000000000-00000. Review.

PMID:
21846157
19.
20.

[The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].

Bernadet-Monrozies P, Rostaing L, Kamar N, Durand D.

Presse Med. 2002 Nov 9;31(36):1714-20. Review. French.

PMID:
12467154
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk